Video Experimental Relacionado

Updated: Jan 7, 2026

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization
05:14

Author Spotlight: Overcoming Anti-VEGF Resistance Through Advanced Vascular Morphology Assessment in Choroidal Neovascularization

Published on: August 11, 2023

1.5K

Características clínicas, características por imágenes y resultados del tratamiento de la telangiectasia macular tipo

Meiqian He1,2,3, Zuyi Yang1,2,3, Youxin Chen4,5

  • 1Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China.

Scientific reports
|January 4, 2026
PubMed
Resumen

No abstract available in PubMed .

Palabras clave:
Inyección de anti-VEGFAgujero macularTelangiectasia macular tipo 2 (MacTel tipo 2)Meta-análisisCaracterísticas multimodales

Más Videos Relacionados

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery07:45

Toxicity Screens in Human Retinal Organoids for Pharmaceutical Discovery

Published on: March 4, 2021

3.8K
Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.1K

Videos de Conceptos Relacionados

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
920